Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Cortagen and Thymalin Interaction: Compatible | Peptide Database

Compound Profiles Cortagen AEDP | Brain Cortex Bioregulator Peptide Cortagen works through epigenetic regulation by penetrating cell nuclei and interacting with DNA to modulate gene expression. In the heart, it affects genes including Pass1, Hsc70, Bmp2, Wnt4,

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Cortagen

AEDP | Brain Cortex Bioregulator Peptide

Cortagen works through epigenetic regulation by penetrating cell nuclei and interacting with DNA to modulate gene expression. In the heart, it affects genes including Pass1, Hsc70, Bmp2, Wnt4, Eps15, and Eps15-rs.

Thymalin

Thymic Peptide Bioregulator | Immune Modulator

Thymalin's immunoprotective action stems from short peptides (KE, EW, EDP) that specifically bind to double-stranded DNA and histone proteins to regulate gene expression. It stimulates differentiation and activity of T-lymphocytes, especially CD4+ and CD8+ cells, promotes cytokine regulation, enhances antigen response, and stimulates stem cell differentiation.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Cortagen with Thymalin?

Yes, Cortagen and Thymalin can generally be taken together. Different organ targets; can be used in comprehensive bioregulator protocols.

Is Cortagen and Thymalin safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Cortagen and Thymalin?

Different organ targets; can be used in comprehensive bioregulator protocols. This assessment has 90% confidence and is based on documented research data.

How should I time Cortagen and Thymalin?

Cortagen has a half-life of Minutes (short peptide); effects persist via epigenetic changes and Thymalin has a half-life of Not established (complex mixture); effects persist for weeks. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Community Research

Join others researching VIP — share findings, ask questions, and learn from real experiences Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuropeptide belonging to the glucagon/secretin superfamily. It is produced in many tissues including the gut, pancreas, and brain. VIP has potent vasodilatory, anti-inflammatory, and immunomodulatory effects. It binds to VPAC1 and VPAC2 receptors, triggering cAMP-mediated signaling cascades. Research shows therapeutic potential for pulmonary hypertension, diabetes, neurological disorders, and autoimmune conditions. VIP binds to VPAC1 and VPAC2 G protein-coupled receptors, activating adenylyl cyclase and increasing intracellular cAMP and PKA activity. This triggers phosphorylation of CREB and other transcription factors. VIP causes vasodilation through NO-dependent and independent mechanisms, stimulates intestinal secretion, relaxes smooth muscle, inhibits gastric acid secretion, and has positive inotropic/chronotropic cardiac effects.

Source: peptide-db.com ↗

Research Indications

Clinical trials showed effects comparable to benzodiazepines; 40% rapid response within 1-3 days. Reduces stress hormones and balances neurotransmitters without sedation. Unlike benzodiazepines, provides relief without tolerance, withdrawal, or dependency. Improves focus, attention, and mental clarity. BDNF-mediated neuroplasticity supports memory formation. Rapidly elevates BDNF expression, supporting neuronal survival. Enhances ability to cope with psychological stress.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Standard administration route; allows precise dosing and rapid hormone stimulation. Gonadotropin stimulation 100-200mcg Single dose or 2-3x weekly SubQ Fertility support 0.4-1.0 nmol/kg (50-150mcg) As directed by physician SubQ (KP-54) Sexual function (clinical) 1 nmol/kg/h 75-minute IV infusion IV infusion

Source: peptide-db.com ↗
Side effects

Common Side Effects

Peeling and flaking (retinoid dermatitis), especially in the first 2-6 weeks Erythema (redness) and skin irritation at the application site Dryness and tightness of the skin Increased photosensitivity (heightened susceptibility to sunburn) Initial acne purging (transient worsening of breakouts in weeks 2-6)

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →